D.A. Davidson & CO. Buys 36,212 Shares of Healthpeak Properties, Inc. $DOC

D.A. Davidson & CO. increased its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 25.6% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 177,481 shares of the real estate investment trust’s stock after purchasing an additional 36,212 shares during the quarter. D.A. Davidson & CO.’s holdings in Healthpeak Properties were worth $2,916,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in DOC. WPG Advisers LLC grew its stake in shares of Healthpeak Properties by 270.2% during the fourth quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock worth $26,000 after buying an additional 1,197 shares during the last quarter. Advocate Investing Services LLC bought a new position in shares of Healthpeak Properties in the 4th quarter valued at $26,000. Elyxium Wealth LLC acquired a new stake in shares of Healthpeak Properties during the 4th quarter valued at $31,000. Clearstead Advisors LLC boosted its holdings in shares of Healthpeak Properties by 166.3% during the 4th quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock valued at $31,000 after acquiring an additional 1,216 shares in the last quarter. Finally, CYBER HORNET ETFs LLC acquired a new stake in shares of Healthpeak Properties during the 2nd quarter valued at $33,000. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Trading Up 0.1%

NYSE DOC opened at $22.52 on Monday. The business has a 50 day simple moving average of $20.47 and a 200 day simple moving average of $18.25. Healthpeak Properties, Inc. has a one year low of $15.70 and a one year high of $22.62. The stock has a market capitalization of $15.53 billion, a P/E ratio of 70.39, a P/E/G ratio of 3.50 and a beta of 1.02. The company has a debt-to-equity ratio of 1.15, a current ratio of 2.96 and a quick ratio of 2.96.

Healthpeak Properties (NYSE:DOC) last issued its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The business had revenue of $752.95 million during the quarter, compared to the consensus estimate of $694.59 million. During the same period in the previous year, the company posted $0.46 earnings per share. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Research analysts expect that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be paid a $0.1017 dividend. The ex-dividend date is Monday, September 14th. This represents a c) annualized dividend and a dividend yield of 5.4%. Healthpeak Properties’s payout ratio is currently 381.25%.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. BMO Capital Markets upped their target price on Healthpeak Properties from $20.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, June 15th. Wells Fargo & Company lifted their price target on Healthpeak Properties from $20.00 to $22.00 and gave the company an “equal weight” rating in a research note on Wednesday, July 15th. Wall Street Zen upgraded Healthpeak Properties from a “sell” rating to a “hold” rating in a report on Sunday, May 10th. Mizuho boosted their price target on Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, July 6th. Finally, Robert W. Baird upped their price objective on Healthpeak Properties from $19.00 to $21.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Four investment analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $20.62.

Insider Buying and Selling at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the sale, the insider owned 7,636 shares in the company, valued at $148,520.20. The trade was a 59.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.23% of the stock is owned by corporate insiders.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.